Last updated 31 days ago
Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program
80 patients around the world
Available in Chile
The aim of this clinical trial is to evaluate the effect of periodontal treatment on the
reduction of HbA1c levels in adult patients with type 2 diabetes mellitus who are users
of the Cardiovascular Health Program and also to measure their quality of life by means
of a survey OHIP-14sp.
Non-surgical periodontal treatment and subsequent follow-up of periodontal clinical
parameters and HbA1c values at 3, 6, 9 and 12 months will be performed.
University of Chile
1Research sites
80Patients around the world
This study is for people with
Diabetes
Diabetes mellitus type 2
Dental and oral disorders
Periodontitis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- Patients enrolled in the PSCV with a diagnosis of type 2 diabetes mellitus and who, in turn, have a glycated hemoglobin ≥ 7% (during the last 6 months).Patients with a diagnosis of periodontitis (≥ 2 non-adjacent teeth with detectable clinical interproximal attachment loss or, attachment loss ≥ 3mm with depth to probing ≥ 3mm on free faces of ≥ 2 teeth, where the attachment loss was not attributed to non-periodontal causes (Papapanou et al., 2018)).
- Patients who have received periodontal treatment during the last year.Pregnancy/lactation, because they are under treatment under the Explicit Health Guarantee 'Oral and Integral Health of Pregnant Women'.Therapy with antibiotics and/or non-steroidal anti-inflammatory drugs (NSAIDs) in the last 6 months prior to the study.
Sites
Universidad Autónoma de Chile
Recruiting
StudyT2D
SponsorUniversity of Chile
Study typeInterventional
Conditions
Diabetes mellitus type 2Periodontitis
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06895980
